Wellington Shields Capital Management Increased Its Main Street Capital (MAIN) Position; Venbio Select Advisor Has Upped Pacira Pharmaceuticals (PCRX) Position By $31.29 Million

January 17, 2018 - By Nellie Frank

Wellington Shields Capital Management Llc increased Main Street Capital Corp (MAIN) stake by 72.05% reported in 2017Q3 SEC filing. Wellington Shields Capital Management Llc acquired 25,000 shares as Main Street Capital Corp (MAIN)’s stock rose 2.44%. The Wellington Shields Capital Management Llc holds 59,700 shares with $2.37 million value, up from 34,700 last quarter. Main Street Capital Corp now has $2.28B valuation. The stock increased 0.54% or $0.2099 during the last trading session, reaching $39.2499. About 60,292 shares traded. Main Street Capital Corporation (NYSE:MAIN) has risen 23.33% since January 17, 2017 and is uptrending. It has outperformed by 6.63% the S&P500.

Venbio Select Advisor Llc increased Pacira Pharmaceuticals Inc (PCRX) stake by 181.54% reported in 2017Q3 SEC filing. Venbio Select Advisor Llc acquired 845,642 shares as Pacira Pharmaceuticals Inc (PCRX)’s stock rose 10.53%. The Venbio Select Advisor Llc holds 1.31 million shares with $49.25M value, up from 465,818 last quarter. Pacira Pharmaceuticals Inc now has $1.65B valuation. The stock increased 0.87% or $0.35 during the last trading session, reaching $40.65. About 107,910 shares traded. Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) has risen 12.40% since January 17, 2017 and is uptrending. It has underperformed by 4.30% the S&P500.

Since August 15, 2017, it had 0 insider buys, and 5 sales for $2.39 million activity. Williams Kristen Marie sold $127,192 worth of stock. STACK DAVID M had sold 28,885 shares worth $1.05 million. Another trade for 1,044 shares valued at $37,741 was made by HASTINGS PAUL J on Tuesday, August 22. $14,858 worth of stock was sold by Riker Lauren Bullaro on Friday, December 15.

Investors sentiment decreased to 1.39 in Q3 2017. Its down 0.23, from 1.62 in 2017Q2. It dived, as 35 investors sold PCRX shares while 37 reduced holdings. 29 funds opened positions while 71 raised stakes. 41.63 million shares or 5.80% more from 39.35 million shares in 2017Q2 were reported. Da Davidson & Co invested 0.01% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). New Jersey-based Bessemer Group has invested 0% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Kazazian Asset Mngmt Ltd Liability Company reported 0.24% stake. Stifel Fincl invested in 0% or 9,367 shares. North Carolina-based Bank Of America Corporation De has invested 0% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Gru Inc holds 0% or 26,346 shares. Armistice Capital Limited Com holds 288,000 shares or 1.27% of its portfolio. Td Cap Mgmt Limited Liability Com has 75 shares. Great Lakes Advsr owns 0.11% invested in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) for 122,083 shares. Lenox Wealth Advisors Inc invested in 0% or 68 shares. Mesirow Finance Investment Management holds 390,685 shares or 0.97% of its portfolio. Parametric Port Associate Limited Liability Corporation, a Washington-based fund reported 96,504 shares. Morgan Stanley owns 0% invested in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) for 94,034 shares. Bancshares Of Montreal Can stated it has 37,180 shares. Advisory Svcs Ntwk Ltd Liability Corporation invested in 0% or 170 shares.

Among 21 analysts covering Pacira Pharmaceuticals (NASDAQ:PCRX), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Pacira Pharmaceuticals had 80 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Buy” rating by H.C. Wainwright given on Thursday, August 3. On Wednesday, December 21 the stock rating was maintained by Mizuho with “Buy”. As per Wednesday, November 29, the company rating was downgraded by Mizuho. The rating was initiated by Goldman Sachs with “Neutral” on Thursday, December 1. RBC Capital Markets maintained the shares of PCRX in report on Sunday, July 30 with “Buy” rating. As per Wednesday, October 4, the company rating was maintained by Bank of America. On Wednesday, February 22 the stock rating was initiated by Canaccord Genuity with “Buy”. Wedbush maintained Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) rating on Wednesday, October 25. Wedbush has “Buy” rating and $87.0 target. Canaccord Genuity maintained the shares of PCRX in report on Thursday, January 4 with “Buy” rating. Canaccord Genuity maintained the stock with “Buy” rating in Friday, September 29 report.

Among 7 analysts covering Street Capital Group (NYSE:MAIN), 1 have Buy rating, 2 Sell and 4 Hold. Therefore 14% are positive. Street Capital Group had 17 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Main Street Capital Corporation (NYSE:MAIN) earned “Neutral” rating by Robert W. Baird on Monday, January 9. RBC Capital Markets maintained the shares of MAIN in report on Thursday, August 11 with “Outperform” rating. Raymond James upgraded Main Street Capital Corporation (NYSE:MAIN) on Tuesday, November 7 to “Hold” rating. The company was reinitiated on Wednesday, April 27 by Janney Capital. Raymond James downgraded Main Street Capital Corporation (NYSE:MAIN) on Thursday, May 11 to “Underperform” rating. The rating was maintained by RBC Capital Markets with “Buy” on Friday, August 4. The firm has “Sell” rating by National Securities given on Thursday, May 11. The rating was downgraded by Citigroup on Thursday, May 11 to “Underperform”. The rating was downgraded by National Securities on Tuesday, December 13 to “Sell”. The firm has “Hold” rating by Robert W. Baird given on Friday, November 3.

Investors sentiment increased to 1.33 in 2017 Q3. Its up 0.10, from 1.23 in 2017Q2. It increased, as 16 investors sold MAIN shares while 39 reduced holdings. 20 funds opened positions while 53 raised stakes. 14.20 million shares or 7.23% more from 13.24 million shares in 2017Q2 were reported. California Pub Employees Retirement Sys has 122,673 shares. State Of Wisconsin Board accumulated 145,282 shares. Raymond James Financial Advsr Inc stated it has 50,156 shares or 0.01% of all its holdings. Confluence Investment Management Ltd Co accumulated 98,998 shares or 0.08% of the stock. Edge Wealth Ltd accumulated 300 shares. Cambridge Investment Research Advsr reported 88,465 shares. Cetera Advisor Network Ltd Liability Company reported 7,504 shares. Sequent Asset Mngmt Ltd accumulated 29,637 shares or 0.69% of the stock. Bokf Na holds 26,665 shares. Archford Capital Strategies Ltd has invested 0.61% in Main Street Capital Corporation (NYSE:MAIN). Webster Bancshares N A has 0% invested in Main Street Capital Corporation (NYSE:MAIN) for 750 shares. Coldstream Mngmt, a Washington-based fund reported 16,858 shares. King Luther Capital Corporation holds 0.01% or 37,130 shares. Asset invested 0.06% in Main Street Capital Corporation (NYSE:MAIN). Callahan Advisors Ltd Liability Corp reported 10,720 shares.

Wellington Shields Capital Management Llc decreased Blackstone Mortgage Trust Inc (NYSE:BXMT) stake by 19,480 shares to 68,249 valued at $2.12M in 2017Q3. It also reduced Alibaba Group Holding Ltd (NYSE:BABA) stake by 7,290 shares and now owns 21,255 shares. Vodafone Group Plc (NASDAQ:VOD) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts